This study evaluated the use of a new ulcer cleansing system and platelet gel in treating non-healing leg ulcers in elderly patients. 16 patients with 27 lesions were treated. Objective measures like wound area, pain, and exudate levels all significantly improved after treatment. Quality of life scores also increased. The cleansing system effectively removed debris from wounds before application of autologous platelet gel, which promoted wound healing. This multi-center observational study suggests the combined treatment may help accelerate healing of hard-to-treat leg ulcers in elderly patients.
EWMA 2013 - Ep519 - DIFFERENTIAL DIAGNOSIS OF LEG ULCERS - ULCERS OF RARE ETI...EWMAConference
András Kovács L.¹, Zsolt Kádár¹, Éva Varga¹, Iván Péter¹, Mehdi Moezzi¹, Imre Schneider¹, Endre Kálmán², Krisztián Molnár³, Dalma Várszegi¹
Department of Dermatology¹, Department of Pathology², Department of Radiology³ University of Pécs, Medical School, Pécs, Hungary
Finvision impact series 1 - ed leases - lessee accountingFinvision
IFRS accounting - Exposure draft on lease accounting has been released recently. The presentation gives an brief overview on the basic principles and how it may impact your organization
Fit-in and be ignored, bland, insipid, invisible and dead (sooner or later). The ONLY way to be coveted by your fans is to Stand-out and BE DiFFERENT...
The challenge facing a leader in today’s highly volatile economy is formidable. It is to create an organization to Stand-Out NOT Fit-In.
Companies that fail to break away from The Competitive Herd and establish themselves as Unique, Distinctive and Remarkable to their Fans fade away and eventually die. Road kill is everywhere.
This is my message to leaders who want to create sustainable success for their organizations; who want to build something special that will be honored by their customers and loved by their employees.
My Six Acts of Leadership will help managers become Leaders. Who focus on execution rather than “the Plan”. Who carve out a One and ONLY competitive claim for their business to separate themselves from their competitors.
Who create memorable experiences for their Fans.
Who serve their employees to deliver Dazzling service.
EWMA 2013 - Ep519 - DIFFERENTIAL DIAGNOSIS OF LEG ULCERS - ULCERS OF RARE ETI...EWMAConference
András Kovács L.¹, Zsolt Kádár¹, Éva Varga¹, Iván Péter¹, Mehdi Moezzi¹, Imre Schneider¹, Endre Kálmán², Krisztián Molnár³, Dalma Várszegi¹
Department of Dermatology¹, Department of Pathology², Department of Radiology³ University of Pécs, Medical School, Pécs, Hungary
Finvision impact series 1 - ed leases - lessee accountingFinvision
IFRS accounting - Exposure draft on lease accounting has been released recently. The presentation gives an brief overview on the basic principles and how it may impact your organization
Fit-in and be ignored, bland, insipid, invisible and dead (sooner or later). The ONLY way to be coveted by your fans is to Stand-out and BE DiFFERENT...
The challenge facing a leader in today’s highly volatile economy is formidable. It is to create an organization to Stand-Out NOT Fit-In.
Companies that fail to break away from The Competitive Herd and establish themselves as Unique, Distinctive and Remarkable to their Fans fade away and eventually die. Road kill is everywhere.
This is my message to leaders who want to create sustainable success for their organizations; who want to build something special that will be honored by their customers and loved by their employees.
My Six Acts of Leadership will help managers become Leaders. Who focus on execution rather than “the Plan”. Who carve out a One and ONLY competitive claim for their business to separate themselves from their competitors.
Who create memorable experiences for their Fans.
Who serve their employees to deliver Dazzling service.
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...EWMAConference
Vania Declair Cohen - RN, MS, Phd - Clinical Pharmacologist, Dermatology Specialist São Paulo - SP - Brazil
Luiz Gustavo Balaguer Cruz – MD, Plastic Surgeon – Hospital 9 de Julho – São Paulo - SP - Brazil
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...EWMAConference
T. SEGOVIA GÓMEZ, M. BERMEJO MARTINEZ, R. MA BONILLA SÁNCHEZ
and I. TOUME(1),
N. PIELENSTICKER(2)
(1)University Hospital Puerta de Hierro Majadahonda Community of Madrid, Spain
(2) Urgo GmbH, Sulzbach, Germany
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...EWMAConference
L. BALTÀ DOMÍNGUEZ, M. BERENGUER PÉREZ, F-J. CORPAS ALCALÁ and C. SANTIAGO FERNÁNDEZ(1)
P. WILKEN(2)
(1) SAP Muntanya. Institut Català de la Salut, Barcelona, Spain
(2) URGO GmbH, Sulzbach, Germany
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigationEWMAConference
David Parsons1 PhD, MRSC CChem
Akhil Seth2 MD, BS
Thomas Mustoe2 MD, FACS
1.ConvaTec Research & Development, Flintshire, Wales, UK
2.Division of Plastic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...EWMAConference
M. NOU, A. KHAU VAN KIEN, T. BEHAR, D. LABAU, C. ZAPPULLA, S. MESTRE-GODIN
J.P. LAROCHE and I. QUÉRÉ (1), M. MARTIN (2)
(1) Vascular Medicine, Hôpital Saint Eloi, CHU de Montpellier, Montpellier, France
(2) Laboratoires URGO, Chenôve, France
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...EWMAConference
L. DAVIS(1), C. BOUVIER(2)
(1) Tissue Viability Nurse, Locking Castle Medical Centre, Highlands Lane, Weston-Super-Mare, UK
(2) Laboratoires Urgo, Chenôve, France
Josef Haik MD MPH, Eyal Winkler MD, Nimrod Farber MD, Moti Harats MD, Oren Weissman MD
Department of Plastic and Reconstructive Surgery and The Burn Unit, Sheba Medical Center
ISRAEL
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...EWMAConference
Alexis Lanteri Parcells, M.D
Ian C. Hoppe, M.D.
Brenon Abernathie, M.D.
Ramazi O. Datiashvili, M.D. Ph.D
University of Medicine and Dentistry of New Jersey
Division of Plastic Surgery
Department of Surgery
Newark, NJ USA
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMAConference
Heyer K1, Blome C1 Storck M2, Schmidt M2, Herberger K1, Imkamp U3, Wild T4, Debus S5, Augustin M1
1) Institute for Health Services Research in Dermatology and Nursing, University Medical Center, Hamburg-Eppendorf
2) Clinic for Vascular and Thoracic surgery, Karlsruhe,
3) Mamedicon GmbH, Magdeburg,
4) German Wound Academy,
5) Clinic for Vascular Surgery, University Medical Center, Hamburg-Eppendorf
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...EWMAConference
Vania Declair Cohen - RN, MS, Phd - Clinical Pharmacologist, Dermatology Specialist São Paulo - SP - Brazil
Luiz Gustavo Balaguer Cruz – MD, Plastic Surgeon – Hospital 9 de Julho – São Paulo - SP - Brazil
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...EWMAConference
T. SEGOVIA GÓMEZ, M. BERMEJO MARTINEZ, R. MA BONILLA SÁNCHEZ
and I. TOUME(1),
N. PIELENSTICKER(2)
(1)University Hospital Puerta de Hierro Majadahonda Community of Madrid, Spain
(2) Urgo GmbH, Sulzbach, Germany
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...EWMAConference
L. BALTÀ DOMÍNGUEZ, M. BERENGUER PÉREZ, F-J. CORPAS ALCALÁ and C. SANTIAGO FERNÁNDEZ(1)
P. WILKEN(2)
(1) SAP Muntanya. Institut Català de la Salut, Barcelona, Spain
(2) URGO GmbH, Sulzbach, Germany
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigationEWMAConference
David Parsons1 PhD, MRSC CChem
Akhil Seth2 MD, BS
Thomas Mustoe2 MD, FACS
1.ConvaTec Research & Development, Flintshire, Wales, UK
2.Division of Plastic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...EWMAConference
M. NOU, A. KHAU VAN KIEN, T. BEHAR, D. LABAU, C. ZAPPULLA, S. MESTRE-GODIN
J.P. LAROCHE and I. QUÉRÉ (1), M. MARTIN (2)
(1) Vascular Medicine, Hôpital Saint Eloi, CHU de Montpellier, Montpellier, France
(2) Laboratoires URGO, Chenôve, France
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...EWMAConference
L. DAVIS(1), C. BOUVIER(2)
(1) Tissue Viability Nurse, Locking Castle Medical Centre, Highlands Lane, Weston-Super-Mare, UK
(2) Laboratoires Urgo, Chenôve, France
Josef Haik MD MPH, Eyal Winkler MD, Nimrod Farber MD, Moti Harats MD, Oren Weissman MD
Department of Plastic and Reconstructive Surgery and The Burn Unit, Sheba Medical Center
ISRAEL
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...EWMAConference
Alexis Lanteri Parcells, M.D
Ian C. Hoppe, M.D.
Brenon Abernathie, M.D.
Ramazi O. Datiashvili, M.D. Ph.D
University of Medicine and Dentistry of New Jersey
Division of Plastic Surgery
Department of Surgery
Newark, NJ USA
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMAConference
Heyer K1, Blome C1 Storck M2, Schmidt M2, Herberger K1, Imkamp U3, Wild T4, Debus S5, Augustin M1
1) Institute for Health Services Research in Dermatology and Nursing, University Medical Center, Hamburg-Eppendorf
2) Clinic for Vascular and Thoracic surgery, Karlsruhe,
3) Mamedicon GmbH, Magdeburg,
4) German Wound Academy,
5) Clinic for Vascular Surgery, University Medical Center, Hamburg-Eppendorf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
EWMA 2013 - Ep526 - USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
1. USE
OF
A
NEW
ULCER
CLEANSING
SYSTEM
AND
OF
PLATELET
GEL
IN
THE
MANAGEMENT
OF
“NON
HEALING”
LEG
ULCERS
IN
ELDERLY
PALUMBO
F.P.1
–
SERANTONI
S.2
–
ABBRITTI
F.3
–
MAZZOLA
G.
4-‐
FAILLA
G.5-‐
DI
SALVO
M.M.5
1
–
LABORATORIO
DI
VULNOLOGIA
–
PALERMO
2
–
CASA
DI
CURA
“VILLA
FIORITA”
–
PRATO
3
–
U.O.
CHIRURGIA
VASCOLARE
–
A.O.
G.
SALVINI,
GARBAGNATE
MILANESE
4
–
U.O.
MEDICINA
TRASFUSIONALE
–
A.O.U.
POLICLINICO,
PALERMO
5
-‐
U.O.
ANGIOLOGIA
–
A.O.U.
VITTORIO
EMANUELE
–
“FERRAROTTO”,
CATANIA
2. USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
Age: 74 - 92 years Average age 81,6 yy
AETIOLOGY
Venous 5
Arterial 2
Mixed 3
Vasculitis 3
Diabetic 3
A
new
technological
advanced
device
was
tested
on
27
lesions
selected
in
16
paTents
in
a
mulTcentric
observaTonal
study.
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
0
2
4
6
8
10
6
10
MALES
FEMALES
3. METHODS
All
paTents
underwent
to
an
anamnesTc
and
clinical
and
instrumental
evaluaTon
(when
required).
Data
were
collected
using
a
schedule
to
detect
wound
characterisTcs.
QL
index
was
administred
to
all
paTents.
In
selected
paTents,
a
mulTlayer,
mulTcomponent,
inelasTc
bandage
was
applied.
Ulcer
Cleansing
System
Device
was
administred
before
platelet
gel
applicaTon.
Autologous
PLT
Gel
was
administred
in
14
paTents.
Only
in
2
paTents
homologous
PLT
Gel
was
administred.
PaTents
were
selected
according
to
condiTons
of
the
injury
at
Tme
T0,
regardless
of
Tme
of
onset
and
treatment
prior
to
enrollment
date.
Criteria
exclusion:
severe
infected
lesions.
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
4. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
ULCERS
AREA
PLANIMETRIC
METHOD
PAIN
VISUAL
SCALE
EXUDATE
N.
DRESSING
CHANGE/WEEK
QUALITY
OF
LIFE
INDEX
(QL)
ACTIVITY,
DAILY
LIVING,
HEALTH,
SUPPORT,
OUTLOOK
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
5. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
RESULTS
In
all
almost
paTents
an
improvement
of
obiecTve
data
was
observed.
ReducTon
of
exudaTon
and
of
inflamaTon
in
the
skin
around
the
ulcers
were
observed
since
the
first
week
of
gel
applicaTon.
These
were
accompanished
by
reducTon
of
average
wound
areas
and
of
pain.
Also
malodour
decreased
since
the
first
week.
Some
paTents
have
reported
the
occurrence
of
burning
in
the
first
two
days
of
applicaTon
of
platelet
gel.
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
6.
USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
PAIN
WOUND
AREAS
0
5
10
15
20
25
30
t0
t1
29,2
20,1
0
1
2
3
4
5
6
7
t0
t1
6,6
2,7
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
-‐
59,9
%
-‐
31,1
%
7. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
QL-‐INDEX
EXUDATE
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
0
0,5
1
1,5
2
2,5
3
3,5
t0
t1
3,4
1,3
8,2
8,4
8,6
8,8
9
9,2
9,4
9,6
9,8
t0
t1
8,8
9,7
-‐61,7%
10,2%
8. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
Cleansing of a pressure ulcer in a patient affected of PAD by device and application of PLT Gel. After 2 weeks
growth of proliferative tissue.
Cleansing of an ulcer occurring in a woman affected of thrombocytemia and application of PLT Gel.
9. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
DISCUSSION
The
aim
of
the
study
was
to
verify
the
effecTveness
a
new
system
of
debridment
using
a
soluTon
based
on
poloxamer
and
moisturisers
like
aloe
vera.
Cleansing
and
debridment,
obtained
with
a
tovel
soaked
in
this
liquid,
was
followed
immediately
by
a
feeling
of
freshness
even
on
very
exuding
and
inflamed
ulcers.
The
applicaTon
of
platelet
gel
in
some
paTent
was
followed
by
the
onset
of
burning
of
vaTable
duraTon
from
a
few
hours
up
to
two
days.
Since
the
first
two
applicaTons
it
was
observed
a
decrease
of
exudate
and
dressing
changes
to
the
reducTon
of
inflamaTon
of
the
Tssue
surrounding
the
wound.
Also
the
bad
odor
was
reduced
unTl
the
disappareance
and
this
has
improved
the
social
life
of
the
elderly
subjects.
The
handling
and
ease
of
use
of
the
new
debridment
system
has
considerably
shortened
Tme
of
PLT
gel
applicaTon.
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
10. USE
OF
A
NEW
SURFACTANT
GEL
WITH
SILVER
SULPHADIAZINE
IN
THE
TREATMENT
OF
CHRONIC
LEG
ULCERS
AND
DIABETIC
FOOT:
ITALIAN
MULTICENTRIC
EXPERIENCE
AKNOWLEDGEMENTS
A
SPECIAL
THANKS
TO
DR.
ELSA
LO
IACONO
AND
DR.
ELENA
PATORNO
FOR
THE
PREPARATION
OF
DATA
ON
PATIENTS.
PALUMBO F.P. – SERANTONI S. – ABBRITTI F.– MAZZOLA G.- FAILLA G.- DI SALVO M.M.
USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE
MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY
CONCLUSIONS
In
almost
all
cases
we
observed
an
improvement
in
the
wounds,
indicated
by:
§ Regression
of
signs
of
inflamaTon;
§ ReducTon
of
exudate
and
fibrin;
§ ReducTon
of
pain
assessed
by
the
paTents;
§ Good
compliance
at
dressing
change;
§ ReducTon
of
malodour;
§ Improving
QL-‐Index
rate.
These
result
suggest
that
a
good
bed
wound
preparaTon
is
important
to
the
next
PLT
gel
acTon,
No
collateral
effects
and
complicaTons
were
reported
in
all
paTents: